Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

29. Februar 2024 08:35 ET | Quelle: SciSparc Ltd

SciSparc Delivers Treatment for Autism Spectrum Disorder Clinical Trial Enabling Commencement of Dosing

The SCI- 210 treatment is now available at clinical site for autism spectrum disorder clinical trial in pediatric patients, in accordance with enrollment initiation TEL AVIV, Israel, Feb. 29,...
29. Januar 2024 07:18 ET | Quelle: SciSparc Ltd

SciSparc Announces Initiation of Patient Recruitment for its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder

The clinical trial for SCI-210 will be conducted in Israel, after which the company aims to move forward with the commercialization process of SCI-210 first in the Israeli market TEL AVIV,...
24. November 2023 08:55 ET | Quelle: SciSparc Ltd

New Hope for Children: SciSparc's patented CBD- Enhanced Solution for Autism Spectrum Disorder

TEL AVIV, Israel, Nov. 24, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) ("Company" or "SciSparc"), a specialty clinical-stage pharmaceutical company focusing on the development of...
16. September 2021 09:00 ET | Quelle: The Spectrum Strategy Group

The Spectrum Strategy Group Launches Season 2 of Autism in Real Life With Temple Grandin

CAPE CORAL, Fla., Sept. 16, 2021 (GLOBE NEWSWIRE) -- Ilia Walsh will launch the season with a conversation about employment with Temple Grandin. Dr. Temple Grandin of CSU has been named one of...